Abstract
Nanoemulsions, usually spherical, are a group of dispersed particles used for pharmaceutical and biomedical aids and vehicles that show great promise for the future of cosmetics, diagnostics, drug therapies and biotechnologies. They exist in a wide variety of forms that are dictated by the particle components. Nanoemulsions are generally considered to be in the size range of less than and around 100 nm in diameter. The particles can exist as water-in-oil and oil-inwater forms, where the core of the particle is either water or oil, respectively. More complex variations also exist but these are often larger. The longer-term properties of the particle are dependent on the composition of the adsorbed material lying at the dispersed droplet interface with the dispersion medium. This has an impact on the partitioning and extraction of droplet contents. Thermodynamically stable particles are characterized by having a very low surface tension and this produces a very large surface area. Nanoemulsions can also include small meta-stable very small-scale emulsions; here the surface properties and chemistry can strongly influence behaviour. Processing, storage and formulation composition can also have an impact on the longevity of a pharmaceutical preparation. Some revolutionary new nanoemulsion droplets based on fluorinated compounds are finding a number of widespread biomedical roles and applications. Developments in nanoemulsion technology are likely to lead to a much greater use of this medium in future pharmaceuticals.
Keywords: topicals, parenterals, encapsulation, surfactant, surface engineering, surface rheology
Current Drug Delivery
Title: Engineering of Nanoemulsions for Drug Delivery
Volume: 2 Issue: 4
Author(s): Dipak K. Sarker
Affiliation:
Keywords: topicals, parenterals, encapsulation, surfactant, surface engineering, surface rheology
Abstract: Nanoemulsions, usually spherical, are a group of dispersed particles used for pharmaceutical and biomedical aids and vehicles that show great promise for the future of cosmetics, diagnostics, drug therapies and biotechnologies. They exist in a wide variety of forms that are dictated by the particle components. Nanoemulsions are generally considered to be in the size range of less than and around 100 nm in diameter. The particles can exist as water-in-oil and oil-inwater forms, where the core of the particle is either water or oil, respectively. More complex variations also exist but these are often larger. The longer-term properties of the particle are dependent on the composition of the adsorbed material lying at the dispersed droplet interface with the dispersion medium. This has an impact on the partitioning and extraction of droplet contents. Thermodynamically stable particles are characterized by having a very low surface tension and this produces a very large surface area. Nanoemulsions can also include small meta-stable very small-scale emulsions; here the surface properties and chemistry can strongly influence behaviour. Processing, storage and formulation composition can also have an impact on the longevity of a pharmaceutical preparation. Some revolutionary new nanoemulsion droplets based on fluorinated compounds are finding a number of widespread biomedical roles and applications. Developments in nanoemulsion technology are likely to lead to a much greater use of this medium in future pharmaceuticals.
Export Options
About this article
Cite this article as:
Sarker K. Dipak, Engineering of Nanoemulsions for Drug Delivery, Current Drug Delivery 2005; 2 (4) . https://dx.doi.org/10.2174/156720105774370267
| DOI https://dx.doi.org/10.2174/156720105774370267 |
Print ISSN 1567-2018 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5704 |
Call for Papers in Thematic Issues
Advances in Drug Delivery for Modern Dentistry
This special issue of Current Drug Delivery is dedicated to exploring the cutting-edge integration of drug delivery technologies within the field of dentistry. As oral diseases remain among the most prevalent health challenges worldwide, there is an urgent need for innovative, effective, and patient-friendly therapeutic approaches. This issue highlights how ...read more
Innovative Materials and Strategies for Delivery of Bioactive Agents
Diverse systems for the delivery of bioactive agents have been developed over the last several decades. The integration of novel materials and advanced fabrication techniques has opened new avenues for addressing long-standing challenges (including overcoming biological barriers, achieving targeted delivery, and enhancing bioavailability) in delivery research. This special issue, "Innovative ...read more
Innovative Nanocarrier Systems for Tumor Targeting and Therapy
In the rapidly evolving field of nanomedicine, innovative nanocarrier systems have emerged as a transformative approach for enhancing tumor targeting and therapeutic efficacy. These advanced systems leverage smart designs—such as stimuli-responsive materials, biomimetic coatings, and multifunctional architectures—to overcome biological barriers, improve tumor accumulation, and minimize off-target toxicity. This Special Issue ...read more
Lipid-Based Drug Delivery Systems.
Lipids are widely used in drug delivery due to their ability to form micelles, enhance the solubility of poorly water-soluble drugs, and their amphiphilic, biodegradable, and biocompatible nature. These properties enhance drug absorption and protection against degradation. These features improve drug absorption and protect against degradation. In contrast, conventional systems ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Respiration and Energy Homeostasis
Current Respiratory Medicine Reviews In Vitro Modeling of the Blood-Brain Barrier: Simplicity Versus Complexity
Current Pharmaceutical Design Mechanism-Based Probing, Characterization, and Inhibitor Design of Glycosidases and Glycosyltransferases
Current Topics in Medicinal Chemistry Kappa Opioids, Salvinorin A and Major Depressive Disorder
Current Neuropharmacology Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Current Cancer Drug Targets Development, Characterization and in vivo Localization Study of Topical 5-Fluorouracil Gels: A Comparative Study with Conventional Formulation
Current Drug Delivery Promising Pharmacological, Molecular and Cellular Treatments of Autoimmune Hepatitis
Current Pharmaceutical Design Drug Targeting to the Brain - A Review
Current Nanoscience The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence
Current Pharmaceutical Design Nucleus Accumbens Dopamine and the Forebrain Circuitry Involved in Behavioral Activation and Effort-Related Decision Making: Implications for Understanding Anergia and Psychomotor Slowing in Depression
Current Psychiatry Reviews The Role of Ionotropic Glutamate Receptors in Childhood Neurodevelopmental Disorders: Autism Spectrum Disorders and Fragile X Syndrome
Current Neuropharmacology Polyphenols and Stem Cells for Neuroregeneration in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Current Pharmaceutical Design Paliperidone: A Clinical Review
Current Drug Therapy Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry The Immune System as a Therapeutic Target for Old and New Drugs in Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Current Neuropharmacology Human Embryonic Stem Cell Therapies for Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Nano-Neurotherapeutics (NNTs): An Emergent and Multifaceted Tool for CNS Disorders
Current Drug Metabolism C. elegans as a Genetic Model System to Identify Parkinson's Disease- Associated Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients
CNS & Neurological Disorders - Drug Targets





